New Product
Roche Announces the Introduction of the COBAS® TaqMan® HBV Test
By
Sep 19, 2008 - 11:49:15 AM

(HealthNewsDigest.com) - The success of antiviral therapy for Chronic Hepatitis B relies upon a viral load test that is highly sensitive and able to quantify HBV DNA across a wide dynamic range. Roche Molecular Diagnostics introduces the FIRST FDA-approved HBV viral load test built upon Roche Real-Time PCR technology.

The COBAS® TaqMan® HBV test for use with the High Pure System provides unprecedented all-around IVD performance to help clinicians drive viral loads of chronic HBV patients to undetectable levels. This newest innovation from Roche expands the COBAS® TaqMan® 48 menu and is backed by the exceptional support you expect from Roche.

www.HealthNewsDigest.com




© Copyright by HealthNewsDigest.com